Guardant Health Inc (NAS:GH)
$ 30.21 -1.3 (-4.13%) Market Cap: 3.70 Bil Enterprise Value: 3.91 Bil PE Ratio: 0 PB Ratio: 53.85 GF Score: 70/100

Guardant Health Inc at Citi Healthcare Conference (Virtual) Transcript

Feb 24, 2022 / 07:45PM GMT
Release Date Price: $65.6 (+10.01%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Okay. Great. Thank you, everyone, for joining us at the Citi Healthcare Conference here. I'm Patrick Donnelly, I cover the tools diagnostics space here at Citi. Happy to have the Guardant team. We have Helmy, AmirAli and Mike, so the co-CEOs and CFO with us. So we'll look to cover a lot of ground.

Obviously topical coming off of the report just last night. So again, thank you guys for the quick turnaround and joining us today. Maybe we can start just touching on the quarter again since it was just last night. And maybe one for you, Helmy, he's reported really strong revenue, $108 million, well above the Street. And the test volumes, particularly were quite strong in -- particularly in the face of the COVID outbreak, Omicron popping up at the end of the quarter there. Can you just talk about, I guess, the resilience of the business to that? And again, it didn't really feel like it impacted things. So again, the momentum as we enter '22 here would be helpful.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot